These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35995146)

  • 21. Predicting personality pathology among adult patients with substance use disorders: effects of childhood maltreatment.
    Bernstein DP; Stein JA; Handelsman L
    Addict Behav; 1998; 23(6):855-68. PubMed ID: 9801721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.
    Zimmerman M; Martinez JH; Morgan TA; Young D; Chelminski I; Dalrymple K
    J Clin Psychiatry; 2013 Sep; 74(9):880-6. PubMed ID: 24107761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endocannabinoid system in borderline personality disorder and antisocial personality disorder: A scoping review.
    Ho W; Kolla NJ
    Behav Sci Law; 2022 Mar; 40(2):331-350. PubMed ID: 35575169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How does dialectical behavior therapy facilitate treatment retention among individuals with comorbid borderline personality disorder and substance use disorders?
    Bornovalova MA; Daughters SB
    Clin Psychol Rev; 2007 Dec; 27(8):923-43. PubMed ID: 17376574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psychopathy and associated personality disorders: searching for a particular effect of the borderline personality disorder?].
    Nioche A; Pham TH; Ducro C; de Beaurepaire C; Chudzik L; Courtois R; Réveillère C
    Encephale; 2010 Jun; 36(3):253-9. PubMed ID: 20620268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for suicidal behavior in borderline personality disorder.
    Soloff PH; Lis JA; Kelly T; Cornelius J; Ulrich R
    Am J Psychiatry; 1994 Sep; 151(9):1316-23. PubMed ID: 8067487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axis I phenomenology of borderline personality disorder.
    Zanarini MC; Gunderson JG; Frankenburg FR
    Compr Psychiatry; 1989; 30(2):149-56. PubMed ID: 2920550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission.
    Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
    Am J Psychiatry; 2004 Nov; 161(11):2108-14. PubMed ID: 15514413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the relationship between posttraumatic stress disorder and deliberate self-harm: the moderating roles of borderline and avoidant personality disorders.
    Gratz KL; Tull MT
    Psychiatry Res; 2012 Aug; 199(1):19-23. PubMed ID: 22521897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Borderline personality disorder: Prevalence and psychiatric comorbidity among male offenders on probation in Sweden.
    Wetterborg D; Långström N; Andersson G; Enebrink P
    Compr Psychiatry; 2015 Oct; 62():63-70. PubMed ID: 26343468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The addition of STEPPS in the treatment of patients with bipolar disorder and comorbid borderline personality features: a protocol for a randomized controlled trial.
    Riemann G; Weisscher N; Goossens PJ; Draijer N; Apenhorst-Hol M; Kupka RW
    BMC Psychiatry; 2014 Jun; 14():172. PubMed ID: 24912456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance use disorders and criminal justice contact among those with co-occurring antisocial and borderline personality disorders: Findings from a nationally representative sample.
    Howard R; Hasin D; Stohl M
    Personal Ment Health; 2021 Feb; 15(1):40-48. PubMed ID: 32588546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised controlled trial of mentalization-based treatment versus structured clinical management for patients with comorbid borderline personality disorder and antisocial personality disorder.
    Bateman A; O'Connell J; Lorenzini N; Gardner T; Fonagy P
    BMC Psychiatry; 2016 Aug; 16(1):304. PubMed ID: 27577562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Borderline personality and substance use in women.
    Feske U; Tarter RE; Kirisci L; Pilkonis PA
    Am J Addict; 2006; 15(2):131-7. PubMed ID: 16595350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of depressed patients with and without borderline personality disorder: implications for interpreting studies of the validity of the bipolar spectrum.
    Galione J; Zimmerman M
    J Pers Disord; 2010 Dec; 24(6):763-72. PubMed ID: 21158598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Call for Increased Psychiatric Training in Emergency Medicine: Physician Attitudes Toward Substance Use Disorders and Co-Occurring Borderline Personality Disorder.
    Appel G; Zaidi SR; Han BH; Avery JJ; Avery JD
    Prim Care Companion CNS Disord; 2020 Aug; 22(4):. PubMed ID: 32791573
    [No Abstract]   [Full Text] [Related]  

  • 37. Comorbidity of borderline personality disorder with other personality disorders in hospitalized adolescents and adults.
    Becker DF; Grilo CM; Edell WS; McGlashan TH
    Am J Psychiatry; 2000 Dec; 157(12):2011-6. PubMed ID: 11097968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychiatric and Substance Use Comorbidity in Treatment-Seeking Injection Opioid Users Referred From Syringe Exchange.
    Kidorf M; Solazzo S; Yan H; Brooner RK
    J Dual Diagn; 2018; 14(4):193-200. PubMed ID: 30332349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Training in Good Psychiatric Management for Borderline Personality Disorder in Residency: An Aide to Learning Supportive Psychotherapy for Challenging-to-Treat Patients.
    Bernanke J; McCommon B
    Psychodyn Psychiatry; 2018; 46(2):181-200. PubMed ID: 29809114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.